Sponsors (4)
The bill strengthens biosecurity by funding standards work and creating a stakeholder forum to improve nucleic acid synthesis screening, but it imposes compliance costs and privacy risks for smaller providers and may not provide enough funding to fully realize and sustain its benefits.
Hospitals, public-health agencies, and healthcare systems will face lower risk of synthesized harmful sequences entering supply chains because improved screening standards aim to reduce biosecurity threats.
Researchers and DNA-synthesis companies will get standardized best practices and measurement tools to improve the accuracy and reliability of nucleic acid synthesis screening, reducing accidental or malicious synthesis risks.
Scientists, standards developers, and students will benefit from predictable federal support because the bill authorizes $5 million per year (FY2026–2030) for NIST measurement science and standards development for biosecurity tools.
Small manufacturers and service providers will face new compliance and conformity-assessment costs to adopt the screening standards, which could be burdensome for smaller firms.
Researchers, customers, and small companies may encounter increased proprietary and privacy risks because broader screening and data-sharing about sequences of concern could expose sensitive information.
The authorized funding level ($5M/year) may be insufficient to fully carry out the measurement research and standards development needed across the industry, slowing expected benefits and leaving gaps in implementation.
Based on analysis of 2 sections of legislative text.
Directs NIST to research and support standards for nucleic acid screening, convene stakeholders, report to Congress, and authorizes $5M/year (FY2026–2030).
Introduced April 28, 2025 by Andrea Salinas · Last progress April 28, 2025
Requires the NIST Director to support research and standard-setting for nucleic acid synthesis screening tools and risk management practices, including convening a stakeholder consortium, producing guidance and a congressional report, and funding measurement research. Authorizes $5,000,000 per year for FY2026–2030 for NIST laboratory activities to carry out the work and adds explicit language to address risks from artificial intelligence in risk-management guidance.